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Independent Left Ventricular 
Morphometric Atlases show 
Consistent Relationships with 
Cardiovascular Risk Factors: A UK 
Biobank study
Kathleen Gilbert1, Wenjia Bai2, Charlene Mauger3, pau Medrano-Gracia  3, 
Avan suinesiaputra  3, Aaron M. Lee4,5, Mihir M. sanghvi4,5, Nay Aung4,5, stefan K. piechnik6, 
stefan Neubauer6, Steffen E. petersen4,5, Daniel Rueckert2 & Alistair A. Young  3,7
Left ventricular (LV) mass and volume are important indicators of clinical and pre-clinical disease 
processes. However, much of the shape information present in modern imaging examinations is 
currently ignored. Morphometric atlases enable precise quantification of shape and function, but 
there has been no objective comparison of different atlases in the same cohort. We compared two 
independent LV atlases using MRI scans of 4547 UK Biobank participants: (i) a volume atlas derived 
by automatic non-rigid registration of image volumes to a common template, and (ii) a surface atlas 
derived from manually drawn epicardial and endocardial surface contours. the strength of associations 
between atlas principal components and cardiovascular risk factors (smoking, diabetes, high blood 
pressure, high cholesterol and angina) were quantified with logistic regression models and five-fold 
cross validation, using area under the RoC curve (AUC) and Akaike Information Criterion (AIC) metrics. 
Both atlases exhibited similar principal components, showed similar relationships with risk factors, and 
had stronger associations (higher AUC and lower AIC) than a reference model based on LV mass and 
volume, for all risk factors (DeLong p < 0.05). Morphometric variations associated with each risk factor 
could be quantified and visualized and were similar between atlases. UK Biobank LV shape atlases are 
robust to construction method and show stronger relationships with cardiovascular risk factors than 
mass and volume.
Left ventricular (LV) morphology and function is important for the evaluation of cardiovascular disease. Changes 
in shape, known as remodeling, can manifest as changes in LV mass, volume, sphericity, wall thickness, and other 
shape indices, due to clinical and pre-clinical disease processes. Previous studies have shown the importance of 
remodeling in the evaluation of 10-year survival rates after a myocardial infarction1–3. Pre-clinical remodeling 
also occurs in asymptomatic individuals prior to the establishment of clinical disease, in response to exposure to 
risk factors and genetic interactions4. However, current shape measures of LV mass and volume ignore most of the 
shape information available in modern medical imaging examinations. The UK Biobank employed cardiac mag-
netic resonance (CMR) imaging to examine the pre-clinical determinants of cardiac disease5,6. This large-scale 
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cohort study has enabled investigation of reference characteristics in healthy participants7, and mechanistic rela-
tionships with cardiovascular risk factors8.
Atlases of the LV have recently been employed to produce statistical shape models, giving highly detailed mor-
phometric information in a standardized coordinate space, suitable for large cohort studies9–11. Compared with 
the American Heart Association 17-myocardial segment model12, atlas-based analyses represent morphology at 
high spatial resolution, enabling quantification of multidimensional statistical information at each point in the 
atlas13. Changes in LV morphometry have been demonstrated in healthy adults who were born prematurely14, 
volunteers with titin-truncating variants15, genetic mutations affecting LV mass16, higher fat mass17, higher blood 
pressure13, and smoking and other risk factors in the Multi-Ethnic Study of Atherosclerosis (MESA)9. Atlas based 
methods have also been used to quantify remodeling patterns in patients with myocardial infarction18, shape 
features associated with response after cardiac resynchronization therapy19, and impairment of function in con-
genital heart disease20.
However, atlas-based shape measures may be influenced by the methods used in their construction, and this 
may affect the resulting shape analyses. Two different types of atlas have been derived to date, using either volume 
image registration10,13,15–17 or surface registration9,14,18–20 methods. The key difference between these approaches 
is in the non-rigid registration techniques used to map the anatomy of each patient’s heart into a common coor-
dinate system. Volumetric image registration methods utilize image intensity features to compute the mapping of 
each case onto the common space. Conversely, surface registration methods use knowledge of the boundaries of 
the heart in the registration process. Each type of atlas may therefore result in different LV shape characteristics. 
To date, there has been no objective comparison of different types of atlas in the same cohort.
Here, we describe the construction of two types of atlas, derived using volume and surface registration meth-
ods respectively, from 4,547 participants of the CMR extension to UK Biobank. By comparing morphometric 
indices between atlases, we investigated the extent to which results were dependent on the method used to con-
struct the atlas. We also examined whether the shape atlases provided stronger relationships with known car-
diovascular risk factors, in comparison with the standard indices of LV mass and volume. We also compared 
morphometric risk factor scores and morphometric shape variations from both atlases to characterize the associ-
ations between LV shape and cardiovascular risk factors.
Results
Of the first 5,065 CMR UK Biobank imaging extension participants, 4,547 common cases could be used to con-
struct volume and surface atlases. The remaining 518 cases had missing information required for one or other 
of the atlases (either missing images or contours). Table 1 shows the participant characteristics. The surface atlas 
construction process is shown in Fig. 1, and the volume atlas construction process is shown in Fig. 2. Of the 4,547 
cases in both atlases, 751 were identified in the reference healthy cohort with no risk factors7.
Figure 3 shows the first three principal component shape modes describing the most variation in the cohort, 
for the surface atlas at both end-diastole (ED) and end-systole (ES). The graphs show the cumulative amount of 
variance explained by each principal component mode for the first 20 modes in each atlas. In the surface atlas, 
the first principal component (explaining over 40% of the total variance) was associated with LV size for both ED 
and ES. The second principal component was associated with LV height to width ratio, or sphericity. The third 
principal component was associated with the mitral valve plane orientation.
Figure 4 shows the first three principal component shape modes of the volume atlas, together with graphs of 
cumulative percentage variance explained for the first 20 modes. Similar to the surface atlas, the first principal 
component was associated with LV size, the second with sphericity and the third with mitral valve plane orien-
tation. Each mode explained a similar proportion of the total variance as the corresponding surface atlas mode.
Age (years) 62 ± 8
Sex (male) 2153 (47%)
Height (cm) 170 ± 9
Weight (kg) 76 ± 15
Body surface area (m2) 1.85 ± 0.21
Systolic blood pressure (mmHg) 139 ± 19
Diastolic blood pressure (mmHg) 79 ± 11
Heart Rate (bpm) 68 ± 11
High blood pressure 1183 (26%)
Smoking (never) 2688 (59%)
Smoking (previous) 1552 (34%)
Smoking (current) 296 (7%)
Diabetes 235 (5%)
Angina 104 (2%)
Asthma 493 (11%)
High Cholesterol 1183 (26%)
Table 1. Participant characteristics for those cases in both atlases (n = 4547). Values are given as 
mean ± standard deviation for continuous variables, and count (%) for categorical variables.
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Table 2 shows the strength of relationships between the risk factors and shape, using logistic regression analy-
sis with five-fold cross validation. Each risk factor was treated as the dependent variable in the logistic regression 
analysis, with 1 for participants positive for the risk factor and 0 for the participants in the reference healthy 
cohort with no risk factors7. For each analysis, the first 20 scores from the ED principal component analysis and 
Figure 1. Surface atlas construction. Left to right: Images to average shape model.
Figure 2. Volume atlas construction. Left to right: Images to shape model.
Figure 3. Principal component analysis results for the surface atlas. (a) ED first three principal components; 
(b) ES first three principal components; (c) ED % variance explained for the first 20 modes; (d) ES % variance 
explained for the first 20 modes. The viewpoint is from the septum with the inferior wall on the left.
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the first 20 scores from the ES principal component analysis were used as independent variables. For comparison, 
a similar logistic regression cross-validation analysis was also performed using the traditional measures of LV 
mass, ED and ES volume as the independent variables (termed “MassVol” in Table 2). Both volume and surface 
atlases gave stronger associations, i.e. larger AUC and lower AIC, between LV shape and all risk factors, com-
pared to the MassVol model. Similar AUC (DeLong p = NS) and AIC values were found between the surface and 
volume atlases. Figure 5 shows the AUC for each risk factor as the number of principal component modes was 
increased from 1 to 50. Approximately three ED and ES modes were needed for the atlases to achieve comparable 
performance to the MassVol model. Performance was stable after about 7 modes.
Morphometric risk factor scores were calculated over the whole cohort using the logistic regression coeffi-
cients to combine component scores into a single z-score for each risk factor. Similar score distributions were 
found for the volume and surface atlases. Figure 5 shows density plots for the morphometric risk factor score 
associated with the risk factors. In each plot two patient groups are shown with the reference cohort (blue) and 
the risk factor positive cohort (orange). Both atlases had higher separation of scores between groups than those 
derived from the MassVol model for all risk factors. Figure 6 shows the 5th and 95th percentiles of the morpho-
metric shape variation associated with each factor. The figure shows the variation in shape, as weighted by the 
model regression coefficients. Angina was associated with an overall outward displacement at ED. Diabetes was 
associated with a bulging at the apex. High blood pressure, high cholesterol, and smoking were associated with a 
septal outward displacement toward the apex but inward near the base.
Figure 4. Principal component analysis results for the volume atlas. (a) ED first three principal components; 
(b) ES first three principal components; (c) ED % variance explained for the first 20 modes; (d) ES % variance 
explained for the first 20 modes. The viewpoint is from the septum with the inferior wall on the left.
Volume Atlas Surface Atlas MassVol
High blood pressure 0.77*** (2157) 0.76*** (2143) 0.68 (2382)
Smoking 0.68* (1174) 0.68* (1156) 0.62 (1213)
Diabetes 0.80*** (857) 0.79*** (869) 0.70 (1001)
High cholesterol 0.73** (1124) 0.73** (1126) 0.65 (1224)
Angina 0.77* (551) 0.76* (528) 0.67 (607)
Table 2. Five-fold cross-validated logistic regression analysis results for binomial categorical factors and LV 
shape (first 20 principal component modes from ED and ES). MassVol model includes LV mass, EDV and 
ESV as independent variables. Each cell has AUC (AIC). *P < 0.05, **P < 0.01, ***P < 0.001, DeLong’s test for 
differences in AUC from MassVol AUC.
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Discussion
The results of this study indicate that LV shape atlases show consistent relationships with cardiovascular risk 
factors, irrespective of the methodology used to derive the atlas. Two types of atlas were constructed from the 
same cohort of CMR examinations, performed as part of the UK Biobank imaging extension. The two atlases used 
different methods to calculate shape characteristics, the volume atlas being based on intensity differences in the 
MRI cine images, and the surface atlas being based on manual contours drawn on the epicardial and endocar-
dial surfaces. However, both had similar principal component shape modes, similar principal components, and 
similar associations with cardiovascular risk factors. These associations were stronger than those with standard 
measures of LV mass and volume, in both atlases. These results suggest that shape features derived from these 
atlases are not severely impacted by methodology, but express real anatomical characteristics related to cardio-
vascular risk factors.
In a previous LV surface atlas study from other asymptomatic cohort (the Multi-Study of Atherosclerosis or 
MESA)9, we found similar shape modes. The shape mode explaining the most variation (first principal shape 
mode) was associated with LV size in both volume and surface atlases, as well as in the MESA atlas. The second 
principal shape mode, orthogonal to the first, describes LV sphericity in both UK Biobank atlases, and also in the 
MESA atlas9. Both LV size and sphericity are known to be associated with adverse events in patients with clinical 
disease and in largely healthy populations1–4.
Both atlases had stronger associations with risk factors than traditional measures of LV morphometry (mass 
and volumes). Similar associations were found between shape and risk factors regardless of atlas construction. 
In addition to providing information on the morphological changes associated with risk factors, these atlases 
can also be used to evaluate individual patients during longitudinal follow-up. For example, z-scores could be 
calculated for each visit, indicating where the patient ranks in relation to the UK Biobank population. A change in 
z-score towards the positive end would indicate a deterioration in LV shape over time. Morphometric risk factor 
scores can then be included in future studies of outcomes over time, for example in Cox models along with sex, 
body mass index and age, in comparison to the risk factors themselves.
Limitations of this study include the cross-sectional nature of the UK Biobank; however, as events are recorded 
into the future, it may be possible to determine the extent to which LV shape features can add to prediction of 
future events. Also, neither cholesterol nor glucose blood test data was available at the time of writing. Risk fac-
tors were self-reported and may suffer from subjective bias. Since the intention of the current study was to com-
pare shape atlases, we did not correct shape scores for sex, age, body mass index, etc. In the future, these atlases 
could be used in conjunction with other factors in multivariate models to better understand shape changes in 
Figure 5. Cumulative area under the curve with increasing numbers of modes included and density of 
morphometric risk factor scores. Scores for the reference (healthy) cohort are shown in blue and those for risk 
factor positive cases are shown in orange.
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more targeted groups, such as those with different environmental or haemodynamic factors. Finally, the surface 
approach requires initial segmentation of the LV contours and landmarks; however, machine learning methods 
show promise to automatically provide these data21.
Conclusions
Both volume and surface cardiac atlases show similar morphometric characteristics, suggesting that shape scores 
derived from LV atlases are robust and quantify real anatomical relationships with cardiovascular risk factors. 
Morphometric scores are more sensitive to detect differences in LV shape associated with cardiovascular risk 
factors than traditional measures of mass and volume.
Methods
study population. The UK Biobank has collected questionnaire data, physical measurements and biolog-
ical samples from 500,000 individuals in the UK22. The imaging extension aims to obtain brain, heart, whole 
body composition, carotid artery, bone and joint imaging in 100,000 participants by 2022. Here, we assessed 
CMR examinations from the first 5,065 UK Biobank imaging extension participants. All participants gave written 
informed consent and the appropriate institutional review boards approved the study protocol (National Research 
Ethics Service North West 11/NW/0382). All research was performed in accordance with the relevant guidelines 
and regulations.
Similar to a recent analysis of relationships between cardiovascular risk factors and LV mass and volume in 
the same cohort8, we investigated the associations between multidimensional LV shape derived from the atlases, 
and each of the following risk factors: high blood pressure, smoking, diabetes, high cholesterol, and angina. High 
blood pressure, diabetes, high cholesterol and angina were taken from self-reported vascular/heart or non-cancer 
conditions or problems diagnosed by physician. Smoking was taken as current tobacco smokers. Participants 
positive for each risk factor were compared with a reference healthy cohort defined according to the criteria 
described in7. The reference cohort excluded all participants with known cardiovascular disease, hypertension, 
respiratory disease, diabetes, hyperlipidaemia, haematological disease, renal disease, rheumatological disease, 
malignancy, symptoms of chest pain or dyspnoea, age over 74 years old, current- or ex-tobacco smokers, those 
taking medication for diabetes, hyperlipidaemia or hypertension and those with BMI ≥ 30 kg/m2.
Figure 6. Morphometric risk factor shapes. The 9th and 95th percentile of the logistic regression models 
rendered at ED and ES. The average shapes were drawn with differences shown in the color scale yellow 
(outward surface movement) to blue (inward surface movement). View point is from the anterior, with septum 
on the left. Displacements are in mm.
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Imaging protocol. The CMR protocol has been described in detail previously23. Briefly, all imaging was 
performed on a wide bore 1.5 T scanner (MAGNETOM Aera, syngo MR D13A, Siemens Healthineers, Erlangen, 
Germany) using a phased-array cardiac coil. Retrospectively gated cine balanced steady-state free precession 
breath-hold acquisitions were performed in horizontal long axis, vertical long axis, left ventricular outflow 
tract orientations, and a short axis stack covering the left and right ventricles. Typical parameters were: TR/
TE = 2.6/1.1 ms, flip angle 80°, GRAPPA factor 2, voxel size 1.8 × 1.8 × 8 mm³ (6 mm for long axis). The actual 
temporal resolution of 32 ms was interpolated to 50 phases per cardiac cycle (~20 ms). No signal or image filtering 
was applied besides distortion correction.
Manual Analysis. The manual contouring process was performed in accordance with the Society of 
Cardiovascular Magnetic Resonance recommendations, as described in detail previously7. Briefly, short axis 
images were contoured at end-diastole (ED) and end-systole (ES) using cvi42 post-processing software (Version 
5.1.1, Circle Cardiovascular Imaging Inc., Calgary, Canada), by eight readers in two core laboratories. The ED 
frame was selected as the first frame after detection of the R wave, and the ES frame was selected as the smallest 
LV blood pool area in the mid-ventricular slice. At both ED and ES, the most basal slice included had at least 50% 
of the LV blood pool surrounded by myocardium. Papillary muscles were included in the blood pool. Left atrial 
contours delineated on the two chamber and four chamber long axis slices, and right ventricular contours on the 
short axis slices, were also used in this study to delineate the extent of the LV and the location of the interven-
tricular septum. Interobserver agreement in mass and volume estimates was excellent, with intra-class correlation 
coefficients of 0.88 and above7.
surface Atlas. The surface atlas was constructed using the method described by Medrano-Gracia et al.9. 
Briefly, a finite element shape model was fitted to the manual contours by least squares optimization. The extent 
of the LV was defined from landmarks on mitral valve (derived from the extent of the left atrium contour) and a 
LV apex point obtained from the cvi42 contour files. The septum was located using the insertions of the RV con-
tour with the LV contour (calculated from the RV endocardial contour). After orienting the model according to 
the landmarks, the endocardial and epicardial surfaces were fitted to the landmarks and short axis contours by 
minimizing the distance between the surfaces and the contour points. Mis-registrations of the contours due to 
differences in the breath-hold position from slice to slice were automatically corrected by shifting the contours 
in-plane to match an initial stiff model fit9. Figure 1 illustrates the formation of the resulting atlas.
Volume Atlas. The volume atlas was constructed using the method described by Bai et al.10. Briefly, a com-
mon template image space and myocardial mesh were used, which were previously derived from high-resolution 
3D MR images [8]. Each short axis image stack was first corrected for breath-hold mis-registration using the same 
method as for the surface atlas construction. Each corrected image volume was then registered to the template 
space10 using non-rigid B-spline image registration24. For each case, the displacement field was stored to give a 
mapping from subject space to template space at each voxel. The template mesh was propagated to each subject 
using the inverse displacement map. Each subject mesh then had the same number of vertices as the template 
mesh. Figure 2 shows the construction of the resulting atlas.
statistics. For each atlas, two statistical shape models were generated, one at ED and the other at ES, using 
principal component analysis. This procedure calculated the principal modes of shape variation across the cohort, 
ordered by amount of variance explained11. Firstly, point clouds were generated on the epicardial and endocardial 
surfaces of the finite element model, or from the volume atlas myocardial mesh. Within each statistical shape 
model, the point clouds were aligned using the Procrustes method25, without scale correction (i.e. translation 
and rotation alignment only). Principal component shape modes were then calculated at ED and ES as described 
previously9,10. Each case could then be represented by a set of principal component scores, which represent the 
amount of each mode present in that case.
Associations between LV shape and risk factors were examined using logistic regression linear models. For 
each risk factor, a separate linear model was generated using that factor as a binary univariate dependent variable, 
and the principal component scores as the independent variables. The strength of the association between shape 
and risk factor was quantified using two metrics: (i) the area under the curve of the receiver operating character-
istic (AUC) and (ii) the Akaike information criterion (AIC). The AUC is a measure of the overall performance of 
the logistic regression model and reflects the probability of correctly ranking any pair of positive/negative cases26. 
A value closer to 1.0 is indicative of a better model. The AIC is a measure of relative quality of the model, with 
lower values indicating better goodness of fit corrected for the independent variables27. To prevent overfitting, a 
five-fold cross validation scheme was employed in which the dataset was randomly divided into five groups, and 
the model trained on 4/5 and tested on the remaining 1/5 for each of the five groups. For comparison, logistic 
regression cross-validation models were also formed using ED volume, ES volume and LV mass as the independ-
ent variables, and the strengths of association compared with the shape atlases. Significant improvements in AUC 
were tested using DeLong’s test28.
Morphometric risk factor scores were derived from the logistic regression coefficients obtained for each risk 
factor, as follows. The logistic regression coefficients represent a linear combination of principal shape modes 
which best describe differences between the reference cohort and the risk factor positive participants. Therefore, 
a combined score was calculated by multiplying each principal component score by its corresponding logistic 
regression weight and summing over components. These scores were calculated for all participants and normal-
ized into z-scores. These scores provide a simple way of quantifying shape characteristics for each case in relation 
to the population. Similarly, a morphometric risk factor shape variation could be calculated to visualize the shape 
change associated with the morphometric score.
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Statistical analysis was performed using R (version 3.3.0) Statistical Software29 and the caret package30.
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recruitment process.
Data Availability
UK Biobank encourages and provides as wide access as possible to its data and samples for health-related research 
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in the UK and internationally, without preferential or exclusive access for any user. Data can be sought directly 
from UK Biobank via online application at http:// www.ukbiobank.ac.uk/register-apply/. The atlases generated in 
this paper are available from UK Biobank, and statistical shape models from www.cardiacatlas.org.
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